Journal article · 2026 · Open access

Current and emerging therapeutic approaches in Alzheimer’s disease

Aman Chauhan, Rooma Devi, Sukhpal Singh, Rahul Thakur, Karanpreet Bhutani, Rohini Sharma, Asha Kumari, Hemang Kumar, Sanghapriya Pal, Adesh K. Saini

Discover Neuroscience, 21(1) · Published 26 June 2026 · DOI 10.1186/s13064-026-00290-5

Free PDFView at the publisherCite this paper

In brief

“Current and emerging therapeutic approaches in Alzheimer’s disease” is a 2026 journal article by Aman Chauhan and 9 co-authors, published in Discover Neuroscience. OpenAlex counts 3 citations as of 15 November 2026, which puts it in the top 4% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Discover Neuroscience.

Citations
3
Most cited in
2026 (3)
Field-weighted impact
4.30
References
150
Authors
10

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline, memory loss, and behavioral changes. AD is characterized by extracellular amyloid-β plaques, intracellular neurofibrillary tau tangles, synaptic loss, neuroinflammation, mitochondrial dysfunction, and altered brain metabolism. AD is clinically divided into early- and late-onset forms. Only a small proportion of early-onset cases are familial and are attributed to mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2). Most cases of AD, whether both early- and late-onset, are sporadic and influenced by a combination of complex genetic, environmental, and age-related factors. Current therapeutic approaches, such as ChEIs and N-Methyl-D-Aspartate (NMDA) antagonists, can help alleviate symptoms. Monoclonal antibodies target amyloid-β42 (Aβ42) and help attenuate amyloid burden in such patients, but their clinical efficacy is limited and remains a topic of debate within the scientific community. Novel approaches (gene and stem cell therapies to nanotechnology, precision medicine and Artificial Intelligence (AI) driven diagnostics and treatments) are under development stage. Implementing early biomarker-based diagnosis in combination with multimodal treatment approaches could fundamentally shift AD management from symptomatic treatment toward disease-modifying strategies. This review aims to provide a critical evaluation of current and emerging therapeutic strategies for AD along with an integrated analysis of outcomes from unsuccessful and successful clinical trials of the emerging therapeutic innovations, highlighting the associated challenges and future treatment perspectives.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chauhan, A., Devi, R., Singh, S., Thakur, R., Bhutani, K., Sharma, R., Kumari, A., Kumar, H., Pal, S., & Saini, A. K. (2026). Current and emerging therapeutic approaches in Alzheimer’s disease. Discover Neuroscience, 21(1). https://doi.org/10.1186/s13064-026-00290-5

MLA 9

Chauhan, Aman, et al. “Current and emerging therapeutic approaches in Alzheimer’s disease.” Discover Neuroscience, vol. 21, no. 1, 2026. https://doi.org/10.1186/s13064-026-00290-5.

Chicago

Chauhan, Aman, Rooma Devi, Sukhpal Singh, Rahul Thakur, Karanpreet Bhutani, Rohini Sharma, Asha Kumari, Hemang Kumar, Sanghapriya Pal, and Adesh K. Saini. 2026. “Current and emerging therapeutic approaches in Alzheimer’s disease.” Discover Neuroscience 21 (1). https://doi.org/10.1186/s13064-026-00290-5.

Harvard

Chauhan, A. et al. (2026) ‘Current and emerging therapeutic approaches in Alzheimer’s disease’, Discover Neuroscience, 21(1). doi:10.1186/s13064-026-00290-5.

IEEE

A. Chauhan et al., “Current and emerging therapeutic approaches in Alzheimer’s disease,” Discover Neuroscience, vol. 21, no. 1, 2026, doi: 10.1186/s13064-026-00290-5.

BibTeX

@article{chauhan2026current,
  title     = {{Current and emerging therapeutic approaches in Alzheimer’s disease}},
  author    = {Chauhan, Aman and Devi, Rooma and Singh, Sukhpal and Thakur, Rahul and Bhutani, Karanpreet and Sharma, Rohini and Kumari, Asha and Kumar, Hemang and Pal, Sanghapriya and Saini, Adesh K.},
  journal   = {Discover Neuroscience},
  year      = {2026},
  volume    = {21},
  number    = {1},
  doi       = {10.1186/s13064-026-00290-5},
  url       = {https://doi.org/10.1186/s13064-026-00290-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • treatment options
  • amyloid plaques
  • tau tangles
  • cholinesterase inhibitors
  • NMDA receptor antagonists
  • anti-amyloid monoclonal antibodies
  • amyloid-beta 42

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Chauhan, A., Devi, R., Singh, S., Thakur, R., Bhutani, K., Sharma, R., Kumari, A., Kumar, H., Pal, S., & Saini, A. K. (2026). Current and emerging therapeutic approaches in Alzheimer’s disease. Discover Neuroscience, 21(1). https://doi.org/10.1186/s13064-026-00290-5

How many times has this paper been cited?

3 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Discover Neuroscience.

Who wrote this paper?

Aman Chauhan, Rooma Devi, Sukhpal Singh, Rahul Thakur, Karanpreet Bhutani, Rohini Sharma, Asha Kumari, Hemang Kumar, Sanghapriya Pal, Adesh K. Saini.

What is the DOI of this paper?

10.1186/s13064-026-00290-5. The permanent link is https://doi.org/10.1186/s13064-026-00290-5.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.